Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PharmaNutra SpA (IT:PHN)
MILAN:PHN
PharmaNutra SpA (PHN) Stock Price & Analysis
5 Followers
PHN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€43.55 - €63.50
Previous Close€48.3
Volume408.00
Average Volume (3M)7.17K
Market Cap
€467.59M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)46.3
Beta0.42
Next Earnings
Sep 09, 2024EPS EstimateN/A
Last Dividend Ex-Date
May 06, 2024Dividend Yield1.83%
Share Statistics
EPS (TTM)1.04
Shares Outstanding9,680,977
10 Day Avg. Volume13,480
30 Day Avg. Volume7,166
Standard Deviation0.10
R-Squared0.24
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€77.50Price Target Upside60.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
PharmaNutra SpA News
Bulls Say, Bears Say
Bulls Say
International GrowthThe international segment posted growth of 9.4% and continued to drive the group's growth.
Market LeadershipOn the existing business, PHN looks very well placed in a steadily-growing industry thanks to undisputed leadership in solid oral iron supplements, high entry barriers due to IP protection, and a relentless commitment to R&D.
Product InnovationExciting feedback from world partner convention held at PHN’s Pisa HQ at the end of April, strong interest on the new Sucrosomial vitamins.
Bears Say
Market DeclineThe Italian market showed a rare decline of around 3.2%.
ProfitabilityRelated start-up costs limited EBITDA growth and profitability.
Sales PerformanceThe group's sales showed timid growth of 0.5%, slightly below expectations of +2%, penalized by an Italian market which should gradually normalize according to management.
---
Options Prices
Currently, No data available
---
Ownership Overview
68.17% Insiders
0.89% Mutual Funds
0.74% Other Institutional Investors
30.20% Public Companies and
Individual Investors
PHN FAQ
What was PharmaNutra SpA’s price range in the past 12 months?
PharmaNutra SpA lowest stock price was €43.55 and its highest was €63.50 in the past 12 months.
What is PharmaNutra SpA’s market cap?
Currently, no data Available
When is PharmaNutra SpA’s upcoming earnings report date?
PharmaNutra SpA’s upcoming earnings report date is Sep 09, 2024 which is in 43 days.
How were PharmaNutra SpA’s earnings last quarter?
PharmaNutra SpA released its earnings results on May 13, 2024. The company reported €0.27 earnings per share for the quarter, beating the consensus estimate of N/A by €0.27.
Is PharmaNutra SpA overvalued?
According to Wall Street analysts PharmaNutra SpA’s price is currently Undervalued.
Does PharmaNutra SpA pay dividends?
PharmaNutra SpA pays a Annually dividend of €0.85 which represents an annual dividend yield of 1.83%. See more information on PharmaNutra SpA dividends here
What is PharmaNutra SpA’s EPS estimate?
PharmaNutra SpA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmaNutra SpA have?
PharmaNutra SpA has 9,680,977 shares outstanding.
What happened to PharmaNutra SpA’s price movement after its last earnings report?
PharmaNutra SpA reported an EPS of €0.27 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.5%.
Which hedge fund is a major shareholder of PharmaNutra SpA?
Currently, no hedge funds are holding shares in IT:PHN
---
PharmaNutra SpA Stock Smart Score
PHN Stock 12 Month Forecast
Average Price Target
€77.50
▲(60.21% Upside)
Technical Analysis
Best Analysts Covering PHN
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-3.58%
reiterated a buy rating 3 months ago
Copying Giorgio Tavolini's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -3.58% per trade.
---